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Abstract 
Hand washing and the use of alcohol-based hand rubs are recognized as the best ways to prevent 
infection. While prior work has emphasized the role of hand hygiene for healthcare workers, there is 
increasing evidence that patients may also be important in transmitting infection. However, no prior 
studies have considered patient preferences for these products and patients may have different 
perspectives on features of these products that make them acceptable for use. The goal of this study was 
to evaluate hospitalized patients’ preferences for hand sanitizers. 
A tool was developed to assess important characteristics of hand sanitizers from the perspective 
of the patient. 
Twenty patients compared two hand sanitizers each using a standardized survey and rated product 
characteristics. After rating two hand sanitizers, patients were asked to select a product to keep at the 
bedside to determine final preference. Patients ranged in age from 27 years old to 77 years old (mean 
51.1, SD 16.8). Eleven males (55%) and 9 (45%) females participated. The majority (70%) of patients 
worked at least part time and 5% had at least some college education. Seven (35%) patients preferred gel 
products and 13 (65%) patients preferred foam hand sanitizers. For the patients under the age of 50, 80% 
preferred foam compared to 20% who preferred the gel. In contrast, in patients over age 50, 50% 
preferred the foam over the gel.  
The presence of rashes, hobbies, work related activities, occupation, gender, and presence of a 
skin condition were not related to preference. 
Ease of use and application of the product were significantly different between foams and gels. 
The mean ease of use rating for gel was 4.50 compared to 4.96 for foam(p-value=0.04).  Gels were rated 
lower in application compared to foam (4.21 vs. 4.85; p=0.005).  Demographic variables were not 
associated with patient preferences in hand sanitizers, however ease of use and application influenced 
patient product ratings.  
We have demonstrated the usefulness of a modified version of the World Health Organization’s 
method of evaluating hand hygiene product preference in patients. Further work should use a larger 
sample size in order to determine which products patients prefer and test a broader range of products. 
 
  
Background 
Hand hygiene is widely recognized as one of the most important measures in the 
prevention of infection.  Health care associated infections are a major cause of death and 
disability. Hand hygiene is the best way to prevent the spread of pathogens and to reduce 
infections (Allegranzi, Sax, & Pittet, 2013; Benedetta Allegranzi et al., 2013). New technologies 
and products are able to kill germs more efficiently then cleaning with soap and water with many 
options for hand sanitizer products (Boyce, 2013; Ellingson et al., 2014; CDCRiskInstrument). 
The use of alcohol based hand rubs is preferred over hand washing as it is simple, 
effective, and well tolerated. In 2002 and 2009, The World Health Organization and U.S. Center 
for Disease Control provided guidelines for hand hygiene and measured the effectiveness of 
these hand sanitizers(World Health Organiztion 2009; Center of Disease Control 2002). In most 
situations, it is thought that the quickest and most effective way to kill germs and reduce 
infections is through the use of hand sanitizers. 
The Food and Drug Administration considers hand sanitizers and their many forms (gels, 
liquids, foams, wipes) to be over the counter drugs. To meet the criteria for being over the 
counter drugs there are many different kinds of standards and a hand sanitizer must be 
considered “generally recognized as safe and effective” (GRASE) to meet the requirements of 
the Food and Drug Administration.  This is much different than cosmetics which are not 
considered by The Food and Drug Administration. Cosmetics are required to be “safe” through 
lab testing but no claims are made to the effectiveness at reducing 
bacteria.(Kendall,Landers,Kirk,Young 2012) 
Hand sanitizer formulations include active and inactive ingredients.  Inactive ingredients 
may include items like water and polyacrylic acid which is a thickening agent that gives gel hand 
sanitizers its structure (Boyce J.M., 2013).  Many hand sanitizers utilize inactive ingredients to 
add a fragrance or color to the sanitizer.    
The Food and Drug Administration only recognizes two active ingredients that are 
GRASE – alcohol and providine-iodine (Centers Disease Control and Prevention, 2002).  
Providine-iodine is not commonly used and alcohol formulations have been widely adopted 
(WHO, 2009). 
In contrast to formulation, the form includes gels, foams, liquids and wipes.  Individuals 
may prefer one form over the other. Different forms of hand sanitizers are shown in Table 1. 
Type Description Comments 
Liquid Water-like sanitizer 
that can be put in to a 
spray 
Rapid dispersal across 
surfaces, can present 
concern about dripping 
Gel Jelly-like colloid 
dispersed in a semi-
solid form 
Commonly used, well 
tolerated, can leave 
“stickiness” on the hands 
Foam A mass of small 
bubbles formed from 
the infusion of air in to 
solution 
Created during manual 
activation of a dispenser or 
air pressurized canister 
Wipe Small cloth or fabric 
soaked in 
antimicrobial solution 
Effective at removing dirt 
and foreign material from 
the hands 
Table 1. Hand Sanitizer Forms.  
Both the formulation and form that yield the best effectiveness or result for the user. 
Thus, it is both the formulation and form that yield the best overall effectiveness.  
Two products were selected by the researchers for a head to head comparison. Because of their 
wide adoption, availability and brand recognition this project evaluated the use of alcohol based 
hand rub gel compared to a foam. In this study, Purell Gel (PURELL® Advanced Instant Hand 
Sanitizer, 3659-12, GOJO Industries, Akron OH) and Purell Foam (PURELL® Advanced Instant 
Hand Sanitizer Foam, 5792-04, GOJO Industries, Akron OH)  were used along with Avaguard 
Foam (AVAGARD™ FOAM, 38-9019-2712-9, 3M Healthcare, Saint Paul MN).  
Research on the various forms and formulations has primarily been done on health care 
workers but there has been increased attention in the role of patient’s own hands in acquiring 
infections (Aiello  E., 2002; Larson, 1995; Welsh, Flanagan, Hoke, Doebbeling, & Herwaldt, 
2012). In contrast to health care workers, patients may require use of hand sanitizer less 
frequently; thus the ideal formulation and form may be different for patients compared to health 
care workers. 
 
 
 
 
 
 
 
 
Literature Review 
Research has shown that transmission of pathogens in healthcare settings are spread 
mainly through the hands. While many studies have shown that hand hygiene is the single most 
important factor in prevention of infection, compliance with hand hygiene remains low. The 
reasons for poor hand hygiene compliance are complex (Boyce, 2013 Ellingson 2014). These 
factors include preferences, underlying attitudes, prior education, knowledge and the availability of 
products (Kirk, Landers, Young 2012).  
Many hand hygiene improvement programs have focused on healthcare worker 
compliance. However, emerging evidence suggests that patients’ hands harbor important disease-
causing bacteria that may later cause an infection (Landers, 2012). Despite this evidence, the 
literature suggests that very little attention is given to patient hand hygiene when compared to 
healthcare workers (Burnett, 2009). 
Purpose 
In order to address this gap, the purpose of this project was to measure patient preference 
for the form and formulation of hand sanitizer products. We hypothesize that the most desirable 
forms and formulations of hand sanitizers will be different for patients compared to health care 
workers (Ellingson, 2014).  
The World Health Organization has outlined methods to evaluate hand sanitizer products, 
but these have been developed for use in healthcare workers. This project aims to identify the 
features of hand sanitizer that patients prefer including important characteristics such as color, 
smell, texture, irritation/stinging, drying effect, ease of use, speed of drying, and application of 
the product. Patient-reported skin condition after use was also evaluated.  
Significance  
This study is important to determine the factors that determine hand sanitizer preference. 
In this study we believe that products that are better tolerated will be more widely accepted and 
lead to better compliance. Effectiveness is associated with reduction in the bacterial load present 
on the hands. If an alcohol based sanitizer is more comfortable to use for the consumer and has 
good germ killing properties then in real world setting it is more likely to be used.  
Theory 
There are many factors that contribute to infection (Welsh, 2012). These factors are 
illustrated in what is considered the “chain of infection.” This “chain” shows how an infectious 
disease enters and infects a susceptible host (Tweeten 2014). The components of this chain of 
infection begin with the reservoir and causative agent. Important causative agents include 
bacteria such as MRSA, viruses, and parasites. The chain continues with the susceptible host and 
the causative agent passing through a portal of entry. A portal of entry could be an area of 
impaired skin integrity or vulnerable mucous membrane. Finally, the chain of infection continues 
with the mode of transmission which includes coughing, sneezing, touching hands. The process 
can start over with the causative agent and reservoir. 
Hand sanitizers are especially important in breaking this chain of infection. They work at 
every level of infection. For example, they decrease reservoirsin which causative agents can live 
and are effective at reducing transmission. Working across the chain of infection, hand sanitizers 
are a vital part of infection prevention programs.  
 Figure 1. Chain of Infection(Tweeten 2014). 
 
Research Questions 
The research question that will be examined within this project is what are patient 
preferences in hand sanitizers?  
Based on prior clinical and anecdotal experience, we hypothesized that patients will 
prefer the foam hand sanitizer over the gel hand sanitizer. We believe that when asked to 
complete our evaluation of the products the foam hand sanitizer will average a score higher in all 
of our evaluation areas than the gel hand sanitizer.   
Research Design 
This was a head-to-head comparison of two forms of alcohol based hand rubs, gels and 
foams. This study was reviewed by The Ohio State University Institutional Review Board.  If 
any adverse events became apparent  they were to be immediately reported to the PI. Research 
staff was trained in data management and responsible research practices.  All data was be kept in 
a secure location so that identifiable information will not be linked with informed consent forms.  
To verify consent with the test subjects/patients, verbal consent was given by the patient 
before the test was conducted. (Appendix A) The process by which patients were recruited were 
as follows: Following preliminary discussions with nurse managers on potential units we 
identified a 27 bed Hepatology and Infectious Disease Unit.  A “facilitation review” was 
conducted by the Ohio State University Medical Center. Nurses on the unit made patients aware 
of the study.  Flyers and recruitment materials were made available for patients. When patients 
indicated their willingness to participate they were approached for eligibility, the study 
procedures were described and patients were asked if they were interested in participating.  If 
candidates were interested, research staff (e.g., study research assistant) obtained consent and 
answered any questions participants had. Research assistants reviewed procedures and eligibility 
criteria with potential participants to ensure that they meet the inclusion and exclusion criteria. 
Human Subjects 
Consent is important to obtain from test subjects as it identifies those test subjects that 
understand the risks and benefits of such study.  The risks of this study include potential skin 
irritation from hand sanitizer products and mild discomfort when applying the products to the 
hands. However, it must be noted that there is minimal risk for the patient to participate in this 
study as all of the products are FDA approved and therefore are very safe for humans to use.  In 
this study potential benefits outweigh the risks. First, if patient hand hygiene is an effective way 
to reduce the presence of pathogens, this could provide evidence for the widespread adoption of 
patient hand hygiene protocols. For example, patients could be instructed to perform hand 
hygiene at key moments when they are at highest risk of acquiring an infection. Adoption of 
these protocols would require inclusion of hand hygiene as part of the curriculum in nursing and 
health care provider training programs. Finally, these findings would introduce patient hand 
hygiene as an infection prevention measure.  In addition to improving health and preventing 
serious infections, this project has the potential to highlight the role that nurses play in healthcare 
safety. By advocating the adoption of a patient hand hygiene program, nurses can provide an 
important contribution to the health of their patients. 
Population and Sample 
Our population and sample came from eligible subjects from The Ohio State University 
Wexner Medical Center who were able to understand English, were alert and orientated and were 
able to give verbal consent.   
 
Data Collection Procedures and Instruments 
The survey instrument was developed using a consensus-based product evaluation tool 
developed by WHO (2009). This tool was revised for use in patients and included product 
characteristics as well as patient demographics and beliefs about hand hygiene. Patients were 
provided a copy of the tool and were asked to provide their answers to research staff. After using 
each product, participants completed a questionnaire about the products.  After completing the 
tool, patients were asked to select one of the test products that they were allowed to keep. This 
selection was identified as the “product choice” as it is thought to reflect patient’s true 
preference. 
The product evaluation tool was pilot tested in a sample of 5 undergraduate students in 
the Technology Learning Complex (TLC) in the College of Nursing. Following completion of 
the interviews, feedback was solicited about the item contents and revised. Through the pilot 
testing, specific steps were developed for use in the final protocol. Revisions made to the 
protocol during this process include presenting the products in a random order, preparing the 
products by priming each container, placing test products on a table in a uniform manner with 
dispenser spout pointing toward the patient and standardizing the patient selection question. In 
order to reduce bias, after the second product was evaluated, it was removed from the table and 
patients were asked, “To thank you for your participation, I would like to leave one of these 
products for you.  Which one would you like to keep?” 
 
Data analysis methods 
 Demographic variables were collected for each subject and compared for those who perferred gel 
vs. those who preferred foams. Mean rating for each product was calculated and compared using a t-test 
for paired variables. Statistical significance was set at p<.05 for all analyses. 
 
Results 
 Twenty subjects completed the study. Participant characteristics are shown in Table 1. 
 Patient characteristics by preference of foam or gel are shown in Table 2 and mean ratings of 
each product by category are shown in Table 3. 
Characteristic (Mean(SD)) Range  
    
 Age  (51.1years(16.8))21-77  
     
   Number (%)  
 Gender    
  Male 11 (55%)  
  Female 9 (45%)  
 Religion    
  Christian 18 (90%)  
  Atheism 2 (10%)  
 Education    
  High School 7 (35%)  
  Some College 6 (30%)  
  College Graduate 5 (25%)  
  Grad School 2 (10%)  
 Occupation    
  Full Time 12(60%)  
  Part Time 2(10%)  
  None 6(30%)  
 Work 
Related 
   
  Yes 4 (20%)  
  No 16(80%)  
 Non-Work 
Related 
   
  Yes 7 (35%)  
  No 13(65%)  
 Rashes    
  Yes 7 (35%)  
  No 13 (65%) 
 
 
Table 1. Participant Characteristics (n=20) 
 
 
 
 
 
    
  Gel Foam 
Gender Male 27.3% 72.7% 
 Female 44.4% 55.6% 
Religion    
 Christian 37.5% 62.5% 
 Atheism 50% 50% 
Education High School Education or 
Below 
57.1% 42.9% 
Table 2. Characteristics of patients who preferred Gel versus Foam. 
Table 3. Mean participant ratings of Gel and Foam hand sanitizer products (scale of 1-5;1=low, 5=high) 
 
The  majority of both males and females preferred foam hand sanitizers over gels. 
However, what is interesting is that the majority of subjects that have above a high school 
education preferred the foam hand sanitizer, while in contrast those with a high school education 
or below preferred the gel hand sanitizer (Table 2).  Looking at the results within Table 2 
patients reported a preference for the foam sanitizer over the gel sanitizer. When comparing 
preferences within the categories of whether or not the subjects had rashes, work related 
activities that could cause damage to the skin, or non-work related activities that could cause 
damage to the skin, patient preference was always slighted towards the foam hand sanitizer. Due 
to a small sample size, statistical significance testing was not performed. 
 Above High School 
Education 
23.1% 76.9% 
Occupation Full Time 33.3% 66.7% 
 Part time 0.0% 100% 
 Unemployed 50% 50% 
Work Related Activities  No 31.3% 68.8% 
 Yes 50% 50% 
Non-Work Related 
Activities 
No 30.8% 69.2% 
 Yes 42.9% 57.1% 
Rashes No 30.8% 69.2% 
 Yes 42.9% 57.1% 
    
 Gel Foam P-Value 
Color 4.71 4.73 .93 
Smell 3.71 3.46 .56 
Tecture 4.14 4.31 .59 
Irritation 4.93 4.92 .95 
Drying 4.57 4.77 .33 
Ease of use 4.50 4.96 .04 
Application 4.21 4.85 .001 
Speed Drying 4.36 4.61 .09 
Overall 4.21 4.62 .124 
    
 When looking at Table 3 there are two significant p-values that stand out. The p-value for 
the ease of use category and the p-value for the application category. The p-values within these 
categories are considered statistically significant when looking at the preference of hand 
sanitizers. The foam hand sanitizer was rated the highest. Even though the foam hand sanitizer 
was rated the best overall, patients still rated gels highly.  
 
Chapter V: Conclusion 
 To be placed on today’s market, hand sanitizing products must be tested in order to 
determine their safety and efficacy in consumer hands. The combination of efficacy, safety and 
preference is what makes certain hand sanitizers stand out among the rest. This study tested the 
preference of hand sanitizers with the notion that the products were FDA approved and had 
demonstrated efficacy and safety using FDA criteria. While testing for the preference of certain 
hand sanitizers the tolerability of each product was evaluated as well because tolerability factors 
largely into a person’s preference in hand sanitizers.  
 In our review of the literature, we found that most hand hygiene methods and practices 
have been focused on healthcare workers and the facilities that they work in. With more and 
more research in this area there is increasing appreciation that patients should also be engaged in 
hand hygiene interventions (Sunkesula, Kundrapu, Macinga, Donskey 2014).  This study 
demonstrates that patients may have different criteria for rating hand hygiene products and 
product selection in patient-centered programs should be carefully targeted toward their specific 
preferences.  
 We have also shown within this study that the World Health Organization method for 
evaluation of hand sanitizers that is usually used with health care workers can be used with 
patients. However, it is important to have measurements that are validated in patients and to pilot 
test evaluation protocols. This is very important for the prevention of infection as ill patients 
within the hospital are most susceptible to the spread to infection.  
  There were some limitations to this study. One of the main limitations was our sample 
size in which we surveyed only 20 subjects. To get more definitive results for our hypothesis, 
testing more subjects would be the first step in achieving this. A larger sample size would have 
provided more power to detect differences. 
 One study recovered MRSA on 82% of subject’s hands and found that the use of hand 
sanitizer decreased this number from 82% to 33% of positive cultures within the subject field 
(Sunkesula, Kundrapu, Macinga, Donskey 2014). These findings demonstrated that efficacious 
products that are well tolerated and available to patients can play an important role in the 
prevention of infection.  
 This study evaluated preference and tolerability of two forms of hand sanitizer products. 
It may be that other factors such as name brand recognition may be important. However, a great 
number of products are commercially available and FDA-approved. Other studies have shown 
the importance of proving the efficacy of certain hand sanitizing products in particular  
healthcare settings.   
Future studies should evaluate the efficacy of additional types of product formulations 
using various methods to determine if all are equally adept at differentiating between products 
(Edmonds-Williams, Campbell, Macinga 2015).  Thus, another limitation of our study was the 
fact that there were only two products evaluated in two forms. To have a better, more clear 
understanding of patient preferences of hand sanitizers, the use of other forms of hand sanitizers 
could have been initiated. Other forms could have included wipes, lotions, etc. with different 
brands in each form. 
 One of the most surprising conclusions within our study was the fact that the more 
difficult bottle to use, the foam bottle, was rated the highest.  This is not what was expected. The 
expectations were that an easier to use bottle such as the gel bottle would have been rated higher.  
With that said another surprising conclusion within our results is that smell was determined to be 
the lowest ranked category meaning that subjects didn’t like the smell of either alcohol sanitizer. 
This finding is especially important if smell impacts the use of these products. To better control 
this category, this study could have educated patients before the use of these sanitizers. All 
alcohol-based hand rubs have a characteristic alcohol odor in the first 10-15 seconds after 
application as the alcohol evaporates. This study could have told the subjects that the initial 
smell, which is a more aggressive smell, will go away. Along with this education it would be 
important to tell the subjects to use the hand sanitizer and then smell their hands after use and 
then evaluate the smell after the hand sanitizer was completely used. Patient education could 
have been important in reporting accurate smell characteristics for both products.  
 In this pilot study, we did not identify one specific variable or category that influenced 
patient preference of hand sanitizers the most. The key point to take from this study is that the 
methods used to evaluate hand sanitizers in health care workers can be transferred to patients in 
the health care setting. This study showed the modified tool was easy to use, well tolerated, and 
the patients appeared to understand the content of the questions. This suggests that this tool is 
appropriate to use with patients of varying ages, backgrounds, and underlying health problems. 
There were also some limitations within this study that if improved may have influenced patient 
preference and the results thereof.  
 The consistent theme in the research literature is that hand hygiene and its products are 
the most important key to prevention of infection. As demonstrated in this study, it is critically 
important to evaluate product efficacy along with preferences and tolerability testing in the 
intended audience and setting. Improving hand hygiene programs in this manner is essential to  
preventing infection, providing a safe environment of care, and improving patient outcomes..  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Appendix A 
Recruitment Script 
  
 
 
  
  
  
 
  
  
  
Hello, We are conducting a research study about hand sanitizer products and were hoping that you would 
be willing to participate. We are trying to determine the kinds of hand sanitizers that patients prefer. If 
you would like to do it, it takes about 10 minutes for me to show you two kinds of hand sanitizers, for you 
to use them both and then answer a few questions. There are no foreseeable risks to using the hand 
sanitizers.  This project will help us understand what patients think about hand sanitizers.  It is voluntary, 
so you do not have to do it.  If you do not wish to participate, you will still receive usual care and there is 
no penalty or loss of benefits to you.  You can stop doing the study at any time. We will not collect names 
or any other identifying information- it will be completely confidential anonymous. If you have questions 
about your participation or your rights as a subject, I can give you the contact information for the lead 
researcher, Dr. Timothy Landers.  (If desired, leave business card.) Would you be willing to participate in 
this study? If “no” or unable to answer: Thank you for your time.  Have a nice day. If “yes”: That is 
great.  I would like to show you a hand sanitizer, have you use it and ask you some questions about it. 
(Show product #1) Thank you.  I would like to show you a second product and ask you the same 
questions. (show product #2) I have just a few final questions (show demographic questions) (When 
completed with product comparison, make observations about hand condition.) 
 
 
 
 
 
  
 
 
 
 
 
 
 
Appendix B 
Survey Instrument 
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b. Are all the sites named above on the Ohio State list of approved research 
performance sites?   
  Yes 
  No 
If No  
 
  Domestic sites  Provide a letter of support, as applicable  
  International sites  Complete Appendix U 
c. Is the Ohio State PI the lead investigator or is The Ohio State University the lead site 
for collaborative research? 
 Yes 
 No  Go to Question #13 
 Not collaborative research  Go to 
Question #13 
i. Describe the communication between sites that might be relevant to the protection of participants, such as unanticipated 
problems, interim results, and protocol modifications. 
 
 
 
ii. Describe IRB oversight arrangements for each collaborative site (i.e., who will provide IRB review and approval). Provide 
copies of the non-Ohio State approvals, as applicable.  Contact ORRP if requesting that Ohio State University serve as 
the IRB of record.  
 
 
 
 
13.  EXPEDITED REVIEW 
Are you requesting Expedited Review? 
 
  Yes  Complete Appendix B 
  No 
 
14.  SUMMARY OF THE RESEARCH 
Summarize the proposed research using non-technical language that can be readily understood by someone outside the discipline. 
Explain briefly the research design, procedures to be used, risks and anticipated benefits, and the importance of the knowledge that 
may reasonably be expected to result. Use complete sentences (limit 300 words). 
Hand hygiene is the most important means of preventing the transmission of infection and increasing evidence demonstrates that bacteria on the 
patients’ own skin may be the the source of many infections.  However, few efforts have been directed at involving patients in hand hygiene. The 
purpose of this single-group pre-post study is to develop and pilot test an evidence-based patient hand hygiene protocol.  
 
In the first phase of the study, we will gather data on the tolerability, preferences, and acceptability of hand hygiene products among patients and 
collect baseline survey data.  We will ask patients to evaluate several hand hygiene products using a standardized questionnaire (see attached).  
 
Secondly, we will gather samples from the hands of approximately 75 patients on admission and 48 hours post-admission by the ‘glove juice’ metho  
in which a liquid is used to recover bacteria from the hands. In this phase we will maintain normal hospital conditions. 
 
Finally, we will then implement a standardized hand hygiene protocol for patients on a select unit (including the products to be used, timing, and 
patient education components).  This protocol including hand sanitizer products and materials will be developed based on patient preferences from 
the first phase.  We will examine the impact of the protocol in 75 patients by repeating the glove juice sampling procedure described in the first 
phase.  We will perform descriptive analyses and culminates in testing the reduction of pathogens as a result of the patient hand hygiene 
intervention. 
 
Potential risks will be minimized by using approved hand hygiene products.  Benefits will include improved access to hand hygiene materials and 
supplies, lowering rates of hospital acquired infections.  
 
Findings from this study will provide evidence regarding the feasibility of a hand hygiene protocol in an acute care setting with the potential to reduce 
the occurrence of healthcare-associated pathogens transmitted by hospital inpatients.  It will also contribute to knowledge about the acquisition of 
pathogens on the hands of patients. 
 
 
15.  SCIENTIFIC BACKGROUND & LITERATURE REVIEW  
Summarize existing knowledge and previous work that support the expectation of obtaining useful results without undue risk to 
human subjects. Use complete sentences (limit 300 words). 
In order to improve patient safety and prevent infection, national and international guidelines have been developed for hand hygiene compliance by 
healthcare workers (HCWs) (Pittet, 2009; Boyce, 2003; Cookson, 2009).  However, few studies have addressed the importance of patient hand 
hygiene as a means to prevent infection. (Burnett, 2008).  Emerging evidence suggests that most infections may occur as a result of bacteria presen  
within the patient’s own flora, on their skin, and bacteria present in the healthcare environment.  Patients may be involved in the transmission of 
pathogens and HAI risk in four significant ways: 1) through the transfer of pathogens within the environment, 2) by directly spreading pathogens to 
other patients, 3) cross-contamination through HCWs via direct contact, and 4) by in increasing their own risk of an infection from an endogenous 
source.  While well-developed guidelines exist for the timing and techniques of hand hygiene in HCWs, significant questions remain about 
implementing patient hand hygiene programs. Although the World Health Organization’s “5 Moments for hand hygiene” are regarded as the standar  
opportunities for hand hygiene in patient care, similar guidelines do not exist for patients (Sax, 2007).  Finally, effective hand hygiene promotion 
strategies require multimodal approaches, but the ideal components of the education, monitoring, product placement, feedback, and organizational 
strategies to promote patient hand hygiene have not been developed (Haas, 2008). 
 
 
 
16.  RESEARCH OBJECTIVES 
List the specific scientific or scholarly aims of the research study. 
 
The specific aims of this project are to:  
1. Develop an evidence-based patient hand hygiene protocol utilizing current practice recommendations, solicitation of 
input from experts, and convening of patient focus groups to develop a standardized hand hygiene protocol.  Since 
effective hand hygiene strategies must include a multimodal strategy, patient and staff education and training plan 
will be developed to accompany the protocol. 
2.  Determine the feasibility (acceptability, adaptation and demand) of an evidence-based patient hand hygiene 
protocol.  Data will be collected in three key areas of feasibility – acceptability, adaptation, and demand.(Bowen, 
2006).  Evaluation of the acceptability and success of the adaptation of the protocol to hospitalized patients will be 
obtained using instruments designed to measure perceptions of hand hygiene products.  Demand, or usage, will be 
measured using overall consumption and number of dispenser “hits.” 
3.  Estimate the effect size of the patient hand hygiene protocol on the presence of potential pathogens on the 
patients’ hands.  The number of patients with pathogens on their hands before and after the implementation of a 
patient hand hygiene protocol will be determined. Samples will be obtained from hospitalized patients at baseline 
and 48 hours later to test for 5 common pathogens. Then, the hand hygiene protocol will be implemented and 
results compared. 
 
 
17.  RESEARCH METHODS & ACTIVITIES 
a. Identify and describe all interventions and interactions that are to be performed solely for the research study. Distinguish 
research (i.e., experimental) activities from non-research activities. Provide description (e.g., spreadsheet or forms) of data 
being collected. Do not include case report forms for multi-site industry-sponsored or cooperative group studies. 
The first phase of the project will involve recruiting 40 people to develop an evidence-based hand hygiene protocol by assessing patient preference 
for hand sanitizer products and formulations. At Ohio State East University Hospital nurses will be asked to identify patients 
 
If the patient indicates that they would like to hear more about the study or enroll, the research assistant will come in and inform the patient of the 
study and go over the consent form. Once the patient has consented to participate, the research assistant will bring in 4 hand sanitizing products. 
The patient will be surveyed on their impression of the hand sanitizers. See attached survey. This data will be used to develop a hand hygiene 
protocol.  first phase of the project will involve recruiting 75 patients prior to the development of an evidence-based hand hygiene protocol. At the 
select unit nurses will let patients know of the availability of a research study examining patient hand hygiene.  
 
Flyers will be available if the patient would like to read more information. If the patient indicated that they would like to hear more about the study or 
enroll, the research assistant will come in and inform the patient of the study, determine eligibility, and go over the consent form and HIPPA forms. If 
the patient has consented to participate, the research assistant will then begin the study procedure. The research assistant will conduct a glove juice 
procedure in order to detect the presence of pathogens on the skin. This involves the patient putting a non latex glove on their hand. Then the 
research assistant will pour in 75ml standardized of surfactant set at a ph of 7.5 +- .2 and massage the hand for 60 seconds. Then the research 
assistant will remove 10ml out of the glove and put in in the collection tube. The tube will be coded by a unique patient code that is not related to the 
patients ID, but so that it can be matched to the same patient. Usual hand sanitizers will be available for the patients during their stay. The study 
would like to capture the normal patient experience in the hospital. The research assistant will then return 48 hours post admission and he/she will 
repeat the glove juice procedure. Samples will be compared at admission and 48 hours post admission. 
 
The third phase of the project will involve recruiting 75 patients after the development of an evidence-based hand hygiene protocol. At the selected 
unit nurses will let patients know of the availability of a research study examining patient had hygiene. Flyers will be available if the patient would like 
to read more information. If the patient indicated that they would like to hear more about the study or enroll, the research assistant will come in and 
inform the patient of the study, determine eligibility, and go over the consent form. If the patient has consented to participate, the research assistant 
will then begin the study procedure. The research assistant will conduct a glove juice procedure in order to detect the presence of pathogens on the 
skin. This involves the patient putting a non latex glove on their hand. Then the research assistant will pour in 75ml standardized of surfactant set at 
a ph of 7.5 +- .2  and massage the hand for 60 seconds. Then the research assistant will suction 10ml out of the glove and put in in the collection 
tube. The tube will be coded by unique patient code that is not related to the patients ID, but can be matched to the same patient. The participant wi  
be educated on the evidence based hand hygiene protocol. This phase would like to capture protocol adherence through self-reported product use 
and open-ended questions about the acceptability and tolerability of the protocol.  Activation of the dispenser will be recorded by measuring the 
number of “hits” on the dispenser over a 24-hour period using “smart dispensers” with built-in recording technology.  Recording of total product 
consumption will be determined per bed (The Joint Commission, 2009). The research assistant will then return 48 hours post admission and he/she 
will repeat the glove juice procedure. Samples will be compared at admission and 48 hours post admission.  
 
We will then perform descriptive analyses and culminates in testing the reduction of pathogens as a result of the patient hand hygiene intervention 
prior to the protocol development and after the protocol implementation.  Findings from this study will provide evidence regarding the feasibility of a 
hand hygiene protocol in an acute care setting with the potential to reduce the occurrence of healthcare-associated pathogens transmitted by 
hospital inpatients.   
 
 
 
 
b. Check all research activities that apply: 
  Anesthesia (general or local) or sedation  Magnetic Resonance Imaging (MRI) 
  Audio, video, digital, or image recordings  Materials that may be considered sensitive, offensive, 
threatening, or degrading 
          Biohazards (e.g., rDNA, infectious agents, select 
agents, toxins) 
 Non-invasive medical procedures (e.g., EKG, Doppler) 
  Biological sampling (other than blood)      Observation of participants (including field notes) 
  Blood drawing      Oral history (does not include medical history) 
  Coordinating Center  Placebo 
  Data, not publicly available  Pregnancy testing 
  Data, publicly available  Program Protocol (Umbrella Protocol) 
  Data repositories  Complete Appendix C 
(future unspecified use, including research databases) 
 Radiation (e.g., CT or DEXA scans, X-rays, nuclear medicine 
procedures)   Complete Appendix V 
  Deception  Complete Appendix D & Appendix M1  Randomization 
  Devices  Complete Appendix E  Record review (which may include PHI) 
  Diet, exercise, or sleep modifications  Specimen research 
  Drugs or biologics  Complete Appendix F  Stem cell research 
  Emergency research  Storage of biological materials  Complete Appendix H 
(future unspecified use, including repositories) 
  Focus groups  Surgical procedures (including biopsies) 
  Food supplements  Surveys, questionnaires, or interviews (one-on-one) 
  Gene transfer  Surveys, questionnaires, or interviews (group) 
  Genetic testing  Complete Appendix G  Other 
  Internet or e-mail data collection  Specify:  
 
18.  DURATION 
Estimate the time required from each participant, including individual interactions, total time commitment, and long-term follow-
up, if any.  
 
Phase 1 (standard hospital condition pre/post test) will last 30 minutes for participants.  Phase 2 (hand sanitizing product feedback survey)will 
consist of a 15 minute product survey. Phase 3 (hand hygiene protocol implementation pre/post test) will consist of a short educational component 
and then the pre/post procedure lasting a total of 40mins.  No long-term follow-up will be conducted. 
 
 
19.  NUMBER OF PARTICIPANTS 
The number of participants is defined as the number of individuals who agree to participate (i.e., those who provide consent or 
whose records are accessed, etc.) even if all do not prove eligible or complete the study. The total number of research participants 
may be increased only with prior IRB approval. 
a. Provide the total number of participants (or number of participant records, specimens, etc.) for whom you are 
seeking Ohio State University IRB approval.  
 
 250 
b. Explain how this number was derived (e.g., statistical rationale, attrition rate, etc.).  
 
The sample size calculation was develop based on up to 100 patients in the product evaluation group and 75 in each phase of the hand hygiene 
protocol group (total of 150 in hand hygiene protocol group). 
 
For the control/intervention groups, it was assumed that 40% of patients would have one of the five bacteria present at the end of 48 hours which is 
consistent with the existing studies. Using a hypothesized reduction in the number of patients positive for pathogens of 40% with the 40% 
population prevalence, a final sample size of 49 subjects would achieve .80 power at alpha = .05, to detect a 50% reduction using a two-sided 
binomial test.(33) A final sample size of 49 subjects would achieve .83 power at alpha = .05, to detect a 50% reduction (a change in Prob(Y=1) 
from the value of 0.40 to .20) in a logistic regression model.(34)Although prior studies have found a high rate of participation, accounting for a 20% 
attrition rate, 75 subjects should provide a sufficient sample. 
 
c. Is this a multi-site study?  
  Yes   Indicate the total number of participants to be enrolled across all 
sites: 
  No 
 
 
20.  PARTICIPANT POPULATION  
a. Specify the age(s) of the individuals who may participate in the research: 
 Age(s):   ≥ 18 years old  
    
b. Specify the participant population(s).  Check all that apply: 
  Adults  Pregnant women/fetuses  Complete Appendix K 
Do not complete Appendix K unless pregnant women will 
be intentionally recruited and/or studied. 
  Children (< 18 years)  Complete Appendix I 
  Adults with decisional impairment  Complete 
Appendix W  
 Neonates (uncertain viability/nonviable)  Complete 
Appendix K  
  Non-English speaking  Complete Appendix J   Prisoners  Complete Appendix L  
  Student research pools (e.g., psychology, linguistics)  Unknown (e.g., secondary use of data/specimens, non-
targeted surveys, program protocols) Specify:  
c. Describe the characteristics of the proposed participants, and explain how the nature of the research requires/justifies their 
inclusion.  
Inclusion criteria: Men and women, age’s ≥ 18 years old, admitted to the OSUWMC, able to understand English, awake, alert and can provide 
verbal consent for the study procedures. 
 
Rationale for Inclusion Criteria:  Patients ages > 18 years are adults and can provide their consent for participation.  Participants must be English 
speaking because intervention materials, instructions, and surveys/measures are written in English. The study is small and not practical /feasible for 
translator, etc.       
 
d. Will any participants be excluded based on age, gender, race/ethnicity, pregnancy status, language, 
education, or financial status?  
  Yes 
  No 
If Yes  Explain the criteria and reason(s) for each exclusion. Consider the study’s scientific or scholarly aims and risks. 
 
Exclusion Criteria: patients ages <18 years and non-English speaking, inability to sample at least one hand due to the presence of dressing, 
bandages, or open wounds on both hands. 
 
Rationale for Exclusion Criteria: patients ages < 18 years are not legal adults; Intervention materials and surveys/measures are written in 
English. The study is small and not practical /feasible for translator, etc.       
  
e. Are any of the participants likely to be vulnerable to coercion or undue influence? Consider students, 
employees, terminally ill persons, or others who may have limited autonomy. 
  Yes 
  No 
If Yes  Describe additional safeguards to protect participants’ rights and welfare. Consider strategies to ensure voluntary 
participation. 
 
 
 
 
21.  PARTICIPANT IDENTIFICATION, RECRUITMENT, & SELECTION 
a. Provide evidence that you will be able to recruit the necessary number of participants to complete the study.  
Preliminary discssions with nurse managers on potential units have indicated their willingness to participate and that the proposed number of 
subjects could be easily obtained.  The proposed hospital, University Hospital East, is a 404-bed acute care hospital providing the full range of acutr  
care services. 
While willing and interested units have been identified, a “facilitation review” is required by the Ohio State Univesity Medical Center which is 
dependent on IRB approval. 
 
 
b. Describe how potential participants will be identified (e.g., advertising, individuals known to investigator, record review, etc.). 
Explain how investigator(s) will gain access to this population, as applicable.   
 
Nurses on the unit will make patients aware of the study.  Flyers and recruitment materials will be available for patients. If the patient would like to 
know more about the study, agree to be approached for eligibility, or enroll, the study staff will approach potential participants, describe study 
procedures and ask if they are interested in participating.  If candidates are interested, research staff (e.g., study research assistant) will obtain 
consent and answer any questions participants may have.   
 
c. List the names of investigator(s) and/or key personnel who will recruit participants. 
Timothy Landers, Kurt Stevenson, Study Research Assistant (TBD), Anthony Dent 
 
d. Describe the process that will be used to determine participant eligibility. 
 Research assistants will review procedures and eligibility criteria with potential participants to ensure that they meet the inclusion and exclusion 
criteria.  Consultation with PI will occur for any questions. See above for inclusion/exclusion criteria. 
 
e. Describe the recruitment process; including the setting in which recruitment will take place. Provide copies of proposed 
recruitment materials (e.g., ads, flyers, website postings, recruitment letters, and oral/written scripts). 
 
A study flyer with information about the objectives and PI contact information will be available.  Study participants will be made aware of the study in 
the selected unit.  As describe above, participants will be approached by study staff about participation in the study. 
 
f. Explain how the process respects potential participants’ privacy. 
 
Only potential participants who indicate their willingness to discuss the study will be approached. Identifiable information will not collected until 
participant consents to participate in study.  Potential participants will be informed that by choosing not to participate in this study, their medical care 
will not change in any way.  Once participants consent, identifiable information will be stored in a separate and locked filing cabinet with PI. 
Participants will be made aware that there is a follow-up visit at 48 hours post admission and that the study staff will approach them at that time for a 
second test. The study staff will be sure to make sure the time is acceptable for the participant when they return.  
 
 
 
22.  INCENTIVES TO PARTICIPATE 
Will participants receive compensation or other incentives (e.g., free services, cash payments, gift 
certificates, parking, classroom credit, travel reimbursement) to participate in the research study?  
Compensation plans should be pro-rated (not contingent upon study completion) and should consider 
participant withdrawals, as applicable. 
  Yes 
  No 
If Yes  Describe the incentive, including the amount and timing of all payments. 
Participants will keep the hand hygiene products ($25 value). 
 
 
23.  ALTERNATIVES TO STUDY PARTICIPATION 
Other than choosing not to participate, list any specific alternatives, including available procedures or treatments that may be 
advantageous to the subject.  
 
None, patients/families may find the hand hygiene materials helpful. 
  
24.  INFORMED CONSENT PROCESS 
Indicate the consent process(es) and document(s) to be used in the study. Check all that apply.  Provide copies of documents and/o  
complete relevant appendices, as needed. See Consent for Research for templates, HRPP policies Informed Consent Process and 
the Elements of Informed Consent, Documentation of the Informed Consent Process, and Assent and Parental Permission or 
contact ORRP for more information. 
  Assent – Form  Parental Permission – Form 
  Assent – Verbal Script  Parental Permission – Verbal Script  Complete Appendix M2 
  Informed Consent – Form  Translated Consent/Assent – Form(s)  Complete Appendix J 
  Informed Consent – Verbal Script  
Complete Appendix M2 
 Waiver or Alteration of Consent Process  Complete Appendix M1 
  Informed Consent – Addendum  Waiver of Consent Documentation  Complete Appendix M2 
 
b. List the names of investigator(s) and/or key personnel who will obtain consent from participants or their legally 
authorized representatives. 
  N/A 
  
        Timothy Landers, Kurt Stevenson, Study Research Assistant (TBD), Anthony Dent  
c. Who will provide consent or permission (i.e. participant, legally authorized representative, parent and/or guardian)?   N/A 
        The patient will provide informed consent. 
 
d. Describe the consent process. Explain when and where consent will be obtained and how subjects and/or their 
legally authorized representatives will be provided sufficient opportunity (e.g., waiting period, if any) to consider 
participation.  
  N/A 
 
 
Nurses on the unit will identify eligible participants (by adhering to inclusion and exclusion criteria described in a subsequent section).  Nurses will 
approach eligible participants and ask if candidates are interested in participating.  If the patient is interested, research staff (e.g., study research 
assistant) will obtain consent and answer any questions participants may have. The consent form will be signed and a copy made for the 
participant.    
 
e. Explain how the possibility of coercion or undue influence will be minimized in the consent process.    N/A 
 
Participants (or potential participants) will be informed that their participation in this study will not alter their hospital care in any way.  Additionally, 
they will be informed that they can leave the study at any time, with no penalty. 
  
f. Will any other tools (e.g., quizzes, visual aids, information sheets) be used 
during the consent process to assist participant comprehension?  
  Yes  Provide copies of these tools 
  No 
g. Will any other consent forms be used (e.g., for clinical procedures such as 
MRI, surgery, etc. and/or consent forms from other institutions)? 
  Yes  Provide copies of these forms 
  No 
 
25.  PRIVACY OF PARTICIPANTS 
a. Describe the provisions to protect the privacy interests of the participants. Consider the circumstances and nature of 
information to be obtained, taking into account factors (e.g., age, gender, ethnicity, education level, etc.) that may influence 
participants’ expectations of privacy. 
The Principal Investigator and research staff will oversee data collection and maintenance throughout the duration of this project.  If any adverse 
events occur, they will immediately be reported to the PI. 
 
Research staff will be trained in data management and responsible research practices.   
 
Informed consent forms will be kept in a separate and locked filing cabinet in the PI’s office.  All data will be kept in a separate location so that 
identifiable information will not be linked with informed consent forms. 
 
b. Does the research require access to personally identifiable private information?   Yes 
  No 
If Yes  Describe the personally identifiable private information involved in the research.  List the information source(s) (e.g., 
educational records, surveys, medical records, etc.). 
 
Informed consent forms will contain participant’s legal name.  These will be kept in a locked filing cabinet in the PI’s office.  Additionally, participants 
will sign a HIPPA Authorization form so that research staff can utilize medical records to determine name, date of birth, date of admission, current 
medications, and occurrence of infection. Name and DOB will be collected in order to identify where the patient is located upon the 48 hours post 
admission time. Current medications and current infections are mediators that will need to be controlled for in data analysis. 
 
26.  CONFIDENTIALITY OF DATA 
a. Explain how information is handled, including storage, security measures (as necessary), and who will have access to the 
information.  Include both electronic and hard copy records.  Methods for handling and storing data (including the use of 
personal computers and portable storage devices) must comply with university policies.  Restricted data, including protected 
health information, must be encrypted if stored or used on portable devices, if removed from a secure university location, or 
if electronically transmitted. For more information, see Policy on Institutional Data and Research Data Policy. 
 Informed consent forms will be kept in a separate and locked filing cabinet in the PI’s office.  All data will be kept in a separate location so that 
identifiable information will not be linked with informed consent forms. 
 
Participant surveys (and other data) will record only study identification number and no identifying information.   
 
 
b. Explain if any personal or sensitive information that could be potentially damaging to participants (e.g., relating 
to illegal behaviors, alcohol or drug use, sexual attitudes, mental health, etc.) will be collected. 
  N/A 
 
 
 
c. Will you be obtaining an NIH Certificate of Confidentiality?  
  Yes  Provide a copy before you begin the research 
  No 
See HRPP policy Privacy and Confidentiality for more information. 
d. Explain any circumstances (ethical or legal) where it would be necessary to break confidentiality.   N/A 
 
 
 
e. Indicate what will happen to identifiable data at the end of the study.  Primary research data should be retained for a 
minimum of five years after final project closeout.  For more information, see the university’s Research Data Policy. Other 
research-related records should be retained for a period of at least three years after the research has been discontinued (i.e., 
no further data collection, long term follow-up, re-contact, or analysis of identifiable/coded data.)  
       Identifiable data were not collected  
  Identifiers will be permanently removed from the data and destroyed (resulting in de-identified data) 
          Identifiable or coded/linked data will be retained and stored  securely (as appropriate) 
  Identifiable data will be retained and may be made public with participant consent (e.g., ethnographic research) 
 
27.  HIPAA RESEARCH AUTHORIZATION  
Will individually identifiable Protected Health Information (PHI) subject to the HIPAA Privacy Rule requirements be accessed, used, 
or disclosed in the research study?   
  No 
  Yes  Check all that apply:  
  Written Authorization  Provide a copy of the Authorization Form 
  Partial Waiver (recruitment purposes only) Complete Appendix N 
  Full Waiver (entire research study)  Complete Appendix N 
  Alteration (written documentation)  Complete Appendix N  
 
28.  REASONABLY ANTICIPATED BENEFITS 
a. List the potential benefits that participants may expect as a result of this research study. State if there are no direct benefits to 
individual participants. Compensation is not to be considered a benefit.  
 
Patient hand hygiene protocol has the potential to reduce the presence of pathogens and transmission of organisms that may reduce HAI during 
the patient’s hospital stay. 
 
b. List the potential benefits that society and/or others may expect as a result of this research study.  
These findings have important implications for nursing. First, should patient hand hygiene be an effective way to reduce the presence of pathogens, 
this could provide evidence for the widespread adoption of patient hand hygiene protocols. For example, patients could be instructed to perform han  
hygiene at key moments when they are at highest risk of acquiring an infection. Adoption of these protocols would require inclusion of hand hygiene 
as part of the curriculum in nursing and health care provider training programs. Finally, these finding would introduce patient hand hygiene as an 
infection prevention measure.  In addition to improving health and preventing serious infections, this project has the potential to highlight the role tha  
nurses play in healthcare safety. By advocating the adoption of a patient hand hygiene program, nurses can provide an important contribution to the 
health of their patients. 
 
 
 
29.  RISKS, HARMS, & DISCOMFORTS 
a. Describe all reasonably expected risks, harms, and/or discomforts that may apply to the research. Discuss severity and 
likelihood of occurrence. As applicable, include potential risks to an embryo or fetus if a woman is or may become pregnant.  
Consider the range of risks, including physical, psychological, social, legal, and economic.   
 
Patient may experience skin irritation or other adverse reactions while using the hand hygiene products and/or during the ‘glove juice’ sample 
collection procedure.   
 
b. Describe how risks, harms, and/or discomforts will be minimized.  If testing will be performed to identify individuals who may 
be at increased risk (e.g., pregnant women, individuals with HIV/AIDS, depressive disorders, etc.), address timing and 
method of testing; include how positive test results will be handled. 
 
If irritation occurs, the patient will be instructed that they may request at any time to stop participation in the study. 
 
  
30.  MONITORING 
Does the research involve greater than minimal risk (i.e., are the harms or discomforts described in Question #29 beyond 
what is ordinarily encountered in daily life or during the performance of routine physical or psychological tests)? 
  Yes 
  No 
If Yes  Describe the plan to oversee and monitor data collected to ensure participant safety and data integrity. Include the 
following: 
• The information that will be evaluated (e.g., incidence and severity of actual harm compared to that expected);  
• Who will perform the monitoring (e.g., investigator, sponsor, or independent monitoring committee);  
• Timing of monitoring (e.g., at specific points in time, after a specific number of participants have been enrolled); and  
• Decisions to be made as a result of the monitoring process (e.g., provisions to stop the study early for unanticipated 
problems). 
 
 
 
 
31.  ASSESSMENT OF RISKS & BENEFITS 
Discuss how risks to participants are reasonable when compared to the anticipated benefits to participants (if any) and the 
importance of the knowledge that may reasonably be expected to result. 
 
The risk of potential patient skin irritation is a reasonable risk in light of the potential decreased risk for a patient HAI. 
 
 
 
32.  PARTICIPANT COSTS/REIMBURSEMENTS 
a. List any potential costs participants (or their insurers) will incur as a result of study participation (e.g., parking, study drugs, 
diagnostic tests, etc.).  
 
None 
 
b. List any costs to participants that will be covered by the research study. 
 None 
 
 
33.  APPLICATION CONTENTS  
Indicate the documents being submitted for this research project. Check all appropriate boxes. 
 Initial Review of Human Subjects Research Application 
 Appendix A1: Ohio State University Co-Investigators & Key Personnel (questions 4 & 5) 
 Appendix A2: External (non-Ohio State) Co-Investigators & Key Personnel (question 6) 
 Appendix B: Expedited Review – Initial Review (question 13) 
 Appendix C: Data Repositories (question 17b) 
 Appendix D: Deception (question 17b)  
 Appendix E: Devices (question 17b) 
 Appendix F: Drugs or Biologics (question 17b) 
 Appendix G: Genetic Testing (question 17b) 
 Appendix H: Storage of Biological Materials (question 17b) 
 Appendix I: Children (question 20b) 
 Appendix J: Non-English Speaking Participants (questions 20b and 24a) 
 Appendix K: Pregnant Women/Fetuses/Neonates (question 20b) 
 Appendix L: Prisoners (question 20b) 
 Appendix M1: Waiver or Alteration of Consent Process (questions 17b & 24a) 
 Appendix M2: Waiver of Consent Documentation (question 24a) 
 Appendix N: Waiver or Alteration of HIPAA Research Authorization (question 27) 
 Appendix U: Research in International Settings (question 12) 
 Appendix V: Radiation (question 17b) 
 Appendix W: Adults with Decisional Impairment (question 20b) 
 Consent form(s), Assent Form(s), Permission Form(s), and Verbal Script(s), including translated documents (question 24a) 
 HIPAA Research Authorization Form(s) (question 27) 
 Data Collection Form(s) for Investigator-Initiated Studies (question 17a) 
 Data Collection Form(s) involving protected health information (Appendix N) 
 Recruitment Materials (e.g., ads, flyers, telephone or other oral script, radio/TV scripts, internet solicitations) (question 21d) 
 Script(s) or Information Sheet(s), including Debriefing Materials (question 24) 
 Instruments (e.g., questionnaires or surveys to be completed by participants) (question 17b) 
 Other Committee Approvals/Letters of Support (questions 11 & 12) 
 Research Protocol  
 Complete Grant Application or Funding Proposal, as applicable 
 Drug Manufacturer’s Approved Labeling/Investigator’s Drug Brochure (Appendix F) 
 Device Manufacturer’s Approved Labeling (Appendix E) 
 Other supporting documentation and/or materials 
For Multi-Site Clinical Trials supported by DHHS, the submission will also include: 
 DHHS-approved Sample Informed Consent Document (if one exists) 
 DHHS-approved Protocol (if one exists) 
 
34.  ASSURANCE 
PRINCIPAL INVESTIGATOR (or Advisor) 
I agree to follow all applicable federal regulations, guidance, state and local laws, and university policies related to the protection of 
human subjects in research, as well as professional practice standards and generally accepted good research practices for 
investigators, including, but not limited to, the responsibilities described in HRPP policy Responsibilities of Principal Investigators, Co
Investigators and Key Personnel. 
I verify that the information provided in this Initial Review of Human Subjects Research application is accurate and complete.  I will 
initiate this research only after having received notification of final IRB approval. 
  
 
  
 
 
Signature of Principal Investigator (or Advisor) Date 
  
 
   
 Printed name of Principal Investigator (or Advisor)    
DEPARTMENT CHAIR (or Signatory Official) 
As Department Chair (or Signatory Official) for the Principal Investigator, I acknowledge that this research is in keeping with the 
standards set by our unit and that it has met all Departmental/College requirements for review. 
If the PI or any co-investigator is also the Department Chair, the signature of the Dean or other appropriate Signatory Official, 
such as the Associate Dean for Research, must be obtained. 
  
 
  
 
 
Signature of Department Chair Date 
 
 
  
Printed name of Department Chair 
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